PER 0.00% 8.0¢ percheron therapeutics limited

Lokunia,The Statement "RNA based technologies seeing renewed...

  1. 3,335 Posts.
    lightbulb Created with Sketch. 165
    Lokunia,
    The Statement "RNA based technologies seeing renewed investor and Big Pharma interest" would reflect interest in the technology and predominately ISIS.
    If there was still interest in either 1103 or 1102 I would have thought Mark would have been more specific i.e. investor and big pharma continue to show interest in 1103 and 1102.
    As I said no indication that anyone is still interested in OUR products! This does not necessarily mean that there isn't interest, just that Mark has not said so.
    I and the market would probably like to see something more specific on external interest.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $90.10K 1.114M

Buyers (Bids)

No. Vol. Price($)
1 17856 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 13303 1
View Market Depth
Last trade - 14.54pm 19/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.